Chemistry: analytical and immunological testing – Involving an insoluble carrier for immobilizing immunochemicals
Patent
1982-06-15
1984-05-08
Padgett, Benjamin R.
Chemistry: analytical and immunological testing
Involving an insoluble carrier for immobilizing immunochemicals
436542, 436 64, 436 86, 436804, 436811, 436813, 436815, 435 4, 435 7, G01N 3348, G01N 3368
Patent
active
044475454
ABSTRACT:
Disclosed is a technique for screening populations to detect potential bladder cancer patients. The screening test is based on a discovered correlation between the respective ratios of C-reactive protein to total protein in urine and serum and the incidence of bladder cancer.
REFERENCES:
patent: 3960827 (1927-06-01), Bjorklund
patent: 4132769 (1979-01-01), Osther
patent: 4184849 (1980-01-01), Cambiaso et al.
patent: 4269765 (1981-05-01), Matsuda et al.
Chromatography of Proteins, G. Bernardi, [29], pp. 225-339, Methods of Enzymology, vol. 22.
Hydroxyapatite, Bio-Rad Corp., catalogue, pp. 59-64.
Partial Purification of Carcinoembryonic-Reactive Antigen from Breast Neoplasm, etc., Santen et al., Cancer Research 40, 1181-1188, Apr., 1980.
Detection of Bladder Cancer-Associated Antigens in Urine by Micro-Complement Fixation, J. J. Gozzo et al., Surg. Forum 15:117-119, 1974.
Immunological Detection of Bladder Cancer Specific Antigen in Urine, J. J. Gozzo, et al., Fed. Proc. 33:805, 1974.
Immunological Detection of Human Bladder Carcinoma, A. P. Monaco, et al., Annals of Surgery, 182:325-333, 1975.
Immunological Detection and Partial Purification of Human Urinary Bladder Tumor Associated Antigens in Urine, W. Cronin et al., Fed. Proc. 34:1042, 1975.
Partial Purification and Characterization of Urine Components from Patients with Bladder Cancer, W. Cronin et al., Fed. Proc. 35:547, 1976.
Immunological Detection of Human Bladder Carcinoma, A. P. Monaco et al., Urology Digest, pp. 31-32, Apr., 1976.
Use of Heterogenous and Monospecific Antisera for the Diagnosis of Bladder Cancer, J. J. Gozzo et al., J. of Urology, 118:748-751, 1977.
Qualitative Analysis of Tumor Related Components in Bladder Cancer Urines, P. O'Brien et al., Fed. Proc. 36:1327, 1977.
Identification of Urinary Bladder Tumor Associated Antigens in Cancer Urine, W. Cronin et al., Fed. Proc. 36:1327, 1977.
Identification of Tumor Antigens in Urine of Patients with Bladder Cancer, W. Cronin et al., Fed. Proc. 37:1486, 1978.
Qualitative Analysis of Proteinuria Associated with Bladder Cancer, P. O'Brien et al., Invest. Urol., 17:28-32, 1979.
Acute Phase Reactant Proteins in the Clinical Management of Carcinoma of the Bladder, R. Bastable et al., British Journal of Urology, 51:283, 1979.
Reevaluation of C-Reactive Protein in Cancer Sera by Radioimmunoassay and Radial Diffusion, D. Drahovsky et al., Oncology 38:286, 1981.
Prognostic Significance of Serum Proteins in Invasive Bladder Cancer, J. O'Quigley et al., Eur. J. Cancer 17:251, 1981.
Bastable, R. B. et al., J. Urology, vol. 51, pp. 283-289 (1979).
Siboo, R. et al., J. Immunological Methods, vol. 23, pp. 59-67 (1978).
DeFazio Sally R.
Gozzo James J.
Monaco Anthony P.
Moskowitz M.
New England Deaconess Hospital
Padgett Benjamin R.
LandOfFree
Bladder cancer detection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bladder cancer detection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bladder cancer detection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1603075